KSC 2019 (´ëÇѽÉÀåÇÐȸ Á¦63Â÷ Ãß°èÇмú´ëȸ) : 2019-10-20±³À°ÀÏÀÚ : 2019-10-20
±³À°Àå¼Ò : ¿öÄ¿Èú È£ÅÚ Art Ȧ ¿Ü
±³À°ÁÖÁ¦ :
KSC 2019 (´ëÇѽÉÀåÇÐȸ Á¦63Â÷ Ãß°èÇмú´ëȸ)ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258
À̸ÞÀÏ :
herz8@circulation.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 5Á¡ / Çʼö 1Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 8 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ-100000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-70000ÇöÀåµî·Ï: ±³¼ö ¹× °³¿øÀÇ-120000, ÀüÀÓÀÇ/Àü°øÀÇ/±âŸ-90000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-20 Art 08:40~08:55 Pulmonary Hypertension with Significant Left to Right Shunt: How to Treat ¹éÀç¼÷(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-20 Art 08:55~09:10 Treatment of Eisenmenger Syndrome in Adult Àå¼ÒÀÍ(¼¼Á¾º´¿ø)
±³À°½Ã°£ 10-20 Art 09:10~09:25 Pulmonary Thromboembolism in ACHD ¹ÚÁ¤¶û(°æ»óÀÇ´ë)
±³À°½Ã°£ 10-20 Art 09:25~09:40 Combined Pre- and Post-capillary Pulmonary Hypertension in ACHD ±èÇü°ü(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-20 Art 09:40~09:55 Differential Diagnosis of Pulmonary Hypertension in ADHD: Multiple Comorbidity Condition À强¾Æ(¼º±Õ°üÀÇ´ë)
Åä·Ð 10-20 Art 09:55~10:10 Discussion ()
ÈÞ½Ä 10-20 10:10~10:20 Break ()
±³À°½Ã°£ 10-20 Theatre 10:20~10:40 The Past, Present and Future of HF Medical Treatment Barry Greenberg(Univ. of California San Diego USA)
±³À°½Ã°£ 10-20 Theatre 10:40~11:00 The Past, Present and Future of CRT Eugene S. Chung(The Christ Hospital Cincinnati OH USA)
±³À°½Ã°£ 10-20 Theatre 11:00~11:20 The Past, Present and Future of Heart Transplantation Jon A. Kobashigawa(Cedars-Sinai USA)
Åä·Ð 10-20 Theatre 11:20~11:50 Discussion ()
ÈÞ½Ä 10-20 11:50~12:00 Break ()
±³À°½Ã°£ 10-20 Cosmos 12:00~12:20 Combination Therapy of Antihypertensive Drugs for CV Protection Amosartan Family ¼ÕÀϼ®(°æÈñÀÇ´ë)
±³À°½Ã°£ 10-20 Cosmos 12:20~12:40 The Benefits of Intensive Lipid Lowering ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-20 Abstract/Case zone & Moderated Poster zone 12:40~14:00 Case Presentation & Moderated Poster ´Ù°»ç(´Ù¼Ò¼Ó)
±³À°½Ã°£ 10-20 Theatre 14:00~14:25 ÃֽŠ»ç·Ê¸¦ ÅëÇØ º» ÀÇ·á±â°ü-Á¦¾àȸ»ç/±â±âȸ»ç À±¸® Áöħ - ûŹ±ÝÁö¹ý ½ÃÇà ÀÌÈÄ Á¶°Ç¹Ì(¼¿ï¾Æ»êº´¿ø ¹ý¹«ÆÀ)
Åä·Ð 10-20 Theatre 14:25~14:30 Discussion ()
±³À°½Ã°£ 10-20 Theatre 14:30~14:55 º¯ÈÇÏ´Â ¿¬±¸ÃâÆÇÀ±¸® Çѵ¿¼ö(ÇѾçÀÇ´ë ÀÇÇÐÇмúÁöÆíÁýÀÎÇùÀÇȸ ÃâÆÇÀ±¸®À§¿øÀå)
Åä·Ð 10-20 Theatre 14:55~15:00 Discussion ()
±³À°½Ã°£ 10-20 Theatre 15:00~15:25 ÀÇ»çÀ±¸®ÁöħÀÇ ¹ýÀûÇؼ® ¹ÚÇü¿í(´Ü±¹ÀÇ´ë)
Åä·Ð 10-20 Theatre 15:25~15:30 Discussion ()
ÈÞ½Ä 10-20 15:30~15:40 Break ()
±³À°½Ã°£ 10-20 Walker 2 15:40~16:00 How to Select Optimal NOAC in AF Patients Undergoing PCI? - Rivaroxaban vs. Dabigatran vs. Apixaban ¹èÀåȯ(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 10-20 Walker 2 16:00~16:20 How to Manage Blood Thinners during Procedure or Surgery? - Antiplatelet or Anticoagulant for Primary and Secondary Prevention ¾È¼º±Õ(¿¬¼¼¿øÁÖÀÇ´ë)
±³À°½Ã°£ 10-20 Walker 2 16:20~16:40 How to Choose Optimal Blood Thinner after Structural Cardiovascular Intervention? ¹Ú´ö¿ì(¿ï»êÀÇ´ë)
±³À°½Ã°£ 10-20 Walker 2 16:40~17:00 How to Adjust Blood Thinners in Patients with Old Age or CKD? - Dose or Regimen Adjustment According to CrCl vs. GFR ±è¿ø(°æÈñÀÇ´ë)
Åä·Ð 10-20 Walker 2 17:00~17:10 Discussion ()